Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 117K 107K 200K 13.57M 204K 1.4M 566K 7.16M 538K 527K 22.63M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 18.8M 17.1M 32.06M 2.17B 32.7M 225M 90.52M 1.15B 86.13M 84.29M 3.62B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | +0.07% | +21.33% | +53.13% | 258B | |
| -1.45% | -1.59% | +7.10% | +18.80% | 163B | |
| +1.26% | -3.01% | -19.51% | +57.63% | 150B | |
| +4.66% | -4.10% | -55.66% | -16.77% | 60.84B | |
| +1.19% | +2.62% | -11.10% | -8.42% | 53.31B | |
| +0.29% | +1.79% | +10.97% | +40.67% | 53.03B | |
| -1.43% | -3.13% | +5.29% | +62.30% | 50.67B | |
| -1.26% | -1.74% | +19.50% | +65.50% | 49.3B | |
| -2.60% | -1.27% | +30.26% | +83.43% | 45.46B | |
| Average | -0.11% | -0.30% | +0.91% | +39.59% | 98.22B | |
| Weighted average by Cap. | -0.41% | +0.15% | +3.34% | +41.05% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.42M 1.29M 2.42M 164M 2.46M 16.92M 6.82M 86.41M 6.49M 6.35M 273M | 1.98M 1.77M 1.62M 1.47M 2.76M 187M 2.82M 19.35M 7.8M 98.83M 7.42M 7.26M 312M |
| Net income | -16.08M -14.35M -13.17M -11.98M -22.46M -1.52B -22.91M -157M -63.41M -803M -60.34M -59.05M -2.54B | -29.31M -26.17M -24.02M -21.85M -40.96M -2.78B -41.78M -287M -116M -1.46B -110M -108M -4.63B |
| Net Debt | 20.53M 18.33M 16.82M 15.3M 28.68M 1.94B 29.25M 201M 80.96M 1.03B 77.04M 75.39M 3.24B | 22.8M 20.36M 18.68M 17M 31.86M 2.16B 32.5M 223M 89.95M 1.14B 85.59M 83.76M 3.6B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
